PUMA BIOTECHNOLOGY, INC. Other Income and Expense
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Other Income and Expense of $660.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $660.00K.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $401.00K.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $1.00K.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was -$330.00K.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for fiscal 2025 was -$1.52M.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for fiscal 2024 was -$6.87M.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for fiscal 2023 was -$9.97M.
- PUMA BIOTECHNOLOGY, INC. nonoperating income (expense) for fiscal 2022 was -$23.26M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed | Nonoperating Income (Expense) 16 month | Nonoperating Income (Expense) 18 month | Nonoperating Income (Expense) 21 month | Nonoperating Income (Expense) 25 month | Nonoperating Income (Expense) 27 month | Nonoperating Income (Expense) 30 month | Nonoperating Income (Expense) 33 month | Nonoperating Income (Expense) 36 month | Nonoperating Income (Expense) 39 month | Nonoperating Income (Expense) 42 month | Nonoperating Income (Expense) 45 month | Nonoperating Income (Expense) 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $660.00K 10-Q · filed 2026-08-06 | $1.06M 10-Q · filed 2026-08-06 | $1.06M derived: sum of 3 quarters · filed 2026-08-06 | $732.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2026-03-31 | $401.00K 10-Q · filed 2026-05-07 | $402.00K derived: sum of 2 quarters · filed 2026-05-07 | $72.00K derived: sum of 3 quarters · filed 2026-05-07 | -$399.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$329.00K derived: sum of 2 quarters · filed 2026-02-26 | -$800.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.52M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2025-09-30 | -$330.00K 10-Q · filed 2025-11-06 | -$801.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.52M 10-Q · filed 2025-11-06 | -$2.65M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-06-30 | -$471.00K 10-Q · filed 2026-08-06 | -$1.19M 10-Q · filed 2026-08-06 | -$2.31M derived: sum of 3 quarters · filed 2026-08-06 | -$3.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-03-31 | -$717.00K 10-Q · filed 2026-05-07 | -$1.84M derived: sum of 2 quarters · filed 2026-05-07 | -$3.31M derived: sum of 3 quarters · filed 2026-05-07 | -$5.29M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.60M derived: sum of 2 quarters · filed 2026-02-26 | -$4.57M derived: sum of 3 quarters · filed 2026-02-26 | -$6.87M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2024-09-30 | -$1.47M 10-Q · filed 2025-11-06 | -$3.44M derived: sum of 2 quarters · filed 2025-11-06 | -$5.74M 10-Q · filed 2025-11-06 | -$7.73M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-06-30 | -$1.97M 10-Q · filed 2025-08-07 | -$4.27M 10-Q · filed 2025-08-07 | -$6.26M derived: sum of 3 quarters · filed 2026-02-26 | -$8.84M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-03-31 | -$2.30M 10-Q · filed 2025-05-08 | -$4.29M derived: sum of 2 quarters · filed 2026-02-26 | -$6.87M derived: sum of 3 quarters · filed 2026-02-26 | -$9.45M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2023-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.57M derived: sum of 2 quarters · filed 2026-02-26 | -$7.15M derived: sum of 3 quarters · filed 2026-02-26 | -$9.97M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2023-09-30 | -$2.58M 10-Q · filed 2024-11-07 | -$5.16M derived: sum of 2 quarters · filed 2024-11-07 | -$7.97M 10-Q · filed 2024-11-07 | -$23.30M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2023-06-30 | -$2.58M 10-Q · filed 2024-08-01 | -$5.40M 10-Q · filed 2024-08-01 | -$20.72M derived: sum of 3 quarters · filed 2025-02-27 | -$23.41M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2023-03-31 | -$2.82M 10-Q · filed 2024-05-02 | -$18.14M derived: sum of 2 quarters · filed 2025-02-27 | -$20.83M derived: sum of 3 quarters · filed 2025-02-27 | -$23.46M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2022-12-31 | -$15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$18.01M derived: sum of 2 quarters · filed 2025-02-27 | -$20.64M derived: sum of 3 quarters · filed 2025-02-27 | -$23.26M 10-K · filed 2025-02-27 | ||||||||||||||||
| 2022-09-30 | -$2.69M 10-Q · filed 2023-11-02 | -$5.32M derived: sum of 2 quarters · filed 2023-11-02 | -$7.93M 10-Q · filed 2023-11-02 | -$10.33M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2022-06-30 | -$2.63M 10-Q · filed 2023-08-03 | -$5.25M 10-Q · filed 2023-08-03 | -$7.64M derived: sum of 3 quarters · filed 2024-02-29 | -$43.33M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2022-03-31 | -$2.62M 10-Q · filed 2023-05-04 | -$5.01M derived: sum of 2 quarters · filed 2024-02-29 | -$40.70M derived: sum of 3 quarters · filed 2024-02-29 | -$29.13M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2021-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$38.08M derived: sum of 2 quarters · filed 2024-02-29 | -$26.51M derived: sum of 3 quarters · filed 2024-02-29 | -$30.09M 10-K · filed 2024-02-29 | ||||||||||||||||
| 2021-09-30 | -$35.68M 10-Q · filed 2022-11-03 | -$24.12M derived: sum of 2 quarters · filed 2022-11-03 | -$27.70M 10-Q · filed 2022-11-03 | -$31.33M derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2021-06-30 | $11.56M 10-Q · filed 2022-08-04 | $7.99M 10-Q · filed 2022-08-04 | $4.35M derived: sum of 3 quarters · filed 2023-03-02 | -$14.98M derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2021-03-31 | -$3.58M 10-Q · filed 2022-05-05 | -$7.22M derived: sum of 2 quarters · filed 2023-03-02 | -$26.55M derived: sum of 3 quarters · filed 2023-03-02 | -$30.28M derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2020-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$22.97M derived: sum of 2 quarters · filed 2023-03-02 | -$26.70M derived: sum of 3 quarters · filed 2023-03-02 | -$29.39M 10-K · filed 2023-03-02 | ||||||||||||||||
| 2020-09-30 | -$19.33M 10-Q · filed 2021-11-04 | -$23.07M derived: sum of 2 quarters · filed 2021-11-04 | -$25.75M 10-Q · filed 2021-11-04 | -$28.23M derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2020-06-30 | -$3.73M 10-Q · filed 2021-08-05 | -$6.42M 10-Q · filed 2021-08-05 | -$8.90M derived: sum of 3 quarters · filed 2022-03-03 | -$11.33M derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2020-03-31 | -$2.68M 10-Q · filed 2021-05-06 | -$5.16M derived: sum of 2 quarters · filed 2022-03-03 | -$7.60M derived: sum of 3 quarters · filed 2022-03-03 | -$19.24M derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2019-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$4.92M derived: sum of 2 quarters · filed 2022-03-03 | -$16.56M derived: sum of 3 quarters · filed 2022-03-03 | -$36.50M 10-K · filed 2022-03-03 | ||||||||||||||||
| 2019-09-30 | -$2.44M 10-Q · filed 2020-11-05 | -$14.08M derived: sum of 2 quarters · filed 2020-11-05 | -$34.02M 10-Q · filed 2020-11-05 | -$46.16M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2019-06-30 | -$11.64M 10-Q · filed 2020-08-06 | -$31.58M 10-Q · filed 2020-08-06 | -$43.72M derived: sum of 3 quarters · filed 2021-03-01 | -$46.64M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2019-03-31 | -$19.93M 10-Q · filed 2020-05-07 | -$32.08M derived: sum of 2 quarters · filed 2021-03-01 | -$35.00M derived: sum of 3 quarters · filed 2021-03-01 | -$37.89M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2018-12-31 | -$12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$15.06M derived: sum of 2 quarters · filed 2021-03-01 | -$17.95M derived: sum of 3 quarters · filed 2021-03-01 | -$18.90M 10-K · filed 2021-03-01 | ||||||||||||||||
| 2018-09-30 | -$2.92M 10-Q · filed 2019-11-07 | -$5.81M derived: sum of 2 quarters · filed 2019-11-07 | -$6.76M 10-Q · filed 2019-11-07 | -$7.27M derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2018-06-30 | -$2.89M 10-Q · filed 2019-08-09 | -$3.84M 10-Q · filed 2019-08-09 | -$4.35M derived: sum of 3 quarters · filed 2020-02-28 | -$4.09M derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2018-03-31 | -$951.00K 10-Q · filed 2019-05-10 | -$1.46M derived: sum of 2 quarters · filed 2020-02-28 | -$1.20M derived: sum of 3 quarters · filed 2020-02-28 | -$853.00K derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2017-12-31 | -$512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$252.00K derived: sum of 2 quarters · filed 2020-02-28 | $98.00K derived: sum of 3 quarters · filed 2020-02-28 | $435.00K 10-K · filed 2020-02-28 | ||||||||||||||||
| 2017-09-30 | $260.00K 10-Q · filed 2018-11-05 | $610.00K derived: sum of 2 quarters · filed 2018-11-05 | $947.00K 10-Q · filed 2018-11-05 | $1.16M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2017-06-30 | $350.00K 10-Q · filed 2018-08-09 | $687.00K 10-Q · filed 2018-08-09 | $896.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.11M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2017-03-31 | $337.00K 10-Q · filed 2018-05-10 | $546.00K derived: sum of 2 quarters · filed 2019-03-01 | $764.00K derived: sum of 3 quarters · filed 2019-03-01 | $648.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2016-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $427.00K derived: sum of 2 quarters · filed 2019-03-01 | $311.00K derived: sum of 3 quarters · filed 2019-03-01 | $585.00K 10-K · filed 2019-03-01 | ||||||||||||||||
| 2016-09-30 | $218.00K 10-Q · filed 2017-11-09 | $102.00K derived: sum of 2 quarters · filed 2017-11-09 | $376.00K 10-Q · filed 2017-11-09 | $692.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-06-30 | -$116.00K 10-Q · filed 2017-08-09 | $158.00K 10-Q · filed 2017-08-09 | $474.00K derived: sum of 3 quarters · filed 2018-03-09 | $790.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-03-31 | $274.00K 10-Q · filed 2017-05-10 | $590.00K derived: sum of 2 quarters · filed 2018-03-09 | $906.00K derived: sum of 3 quarters · filed 2018-03-09 | $1.13M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2015-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $632.00K derived: sum of 2 quarters · filed 2018-03-09 | $851.00K derived: sum of 3 quarters · filed 2018-03-09 | $996.00K 10-K · filed 2018-03-09 | ||||||||||||||||
| 2015-09-30 | $316.00K 10-Q · filed 2016-11-09 | $535.00K derived: sum of 2 quarters · filed 2016-11-09 | $680.00K 10-Q · filed 2016-11-09 | $789.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-06-30 | $219.00K 10-Q · filed 2016-08-09 | $364.00K 10-Q · filed 2016-08-09 | $473.00K derived: sum of 3 quarters · filed 2017-03-01 | $588.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-03-31 | $145.00K 10-Q · filed 2016-05-10 | $254.00K derived: sum of 2 quarters · filed 2017-03-01 | $369.00K derived: sum of 3 quarters · filed 2017-03-01 | $430.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2014-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $224.00K derived: sum of 2 quarters · filed 2017-03-01 | $285.00K derived: sum of 3 quarters · filed 2017-03-01 | $310.00K 10-K · filed 2017-03-01 | ||||||||||||||||
| 2014-09-30 | $115.00K 10-Q · filed 2015-11-09 | $176.00K derived: sum of 2 quarters · filed 2015-11-09 | $201.00K 10-Q · filed 2015-11-09 | $244.00K derived: sum of 4 quarters · filed 2016-02-29 | $397.00K 10-Q · filed 2014-11-10 | |||||||||||||||
| 2014-06-30 | $61.00K 10-Q · filed 2015-08-10 | $86.00K 10-Q · filed 2015-08-10 | $129.00K derived: sum of 3 quarters · filed 2016-02-29 | $177.00K derived: sum of 4 quarters · filed 2016-02-29 | $282.00K 10-Q · filed 2014-08-11 | |||||||||||||||
| 2014-03-31 | $25.00K 10-Q · filed 2015-05-11 | $68.00K derived: sum of 2 quarters · filed 2016-02-29 | $116.00K derived: sum of 3 quarters · filed 2016-02-29 | $173.00K derived: sum of 4 quarters · filed 2016-02-29 | $221.00K 10-Q · filed 2014-05-12 | |||||||||||||||
| 2013-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $91.00K derived: sum of 2 quarters · filed 2016-02-29 | $148.00K derived: sum of 3 quarters · filed 2016-02-29 | $174.00K 10-K · filed 2016-02-29 | $196.00K 10-K · filed 2014-03-03 | |||||||||||||||
| 2013-09-30 | $48.00K 10-Q · filed 2014-11-10 | $105.00K derived: sum of 2 quarters · filed 2014-11-10 | $131.00K 10-Q · filed 2014-11-10 | $166.00K derived: sum of 4 quarters · filed 2015-03-02 | $153.00K 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $57.00K 10-Q · filed 2014-08-11 | $83.00K 10-Q · filed 2014-08-11 | $118.00K derived: sum of 3 quarters · filed 2015-03-02 | $132.00K derived: sum of 4 quarters · filed 2015-03-02 | $105.00K 10-Q · filed 2013-08-06 | |||||||||||||||
| 2013-03-31 | $26.00K 10-Q · filed 2014-05-12 | $61.00K derived: sum of 2 quarters · filed 2015-03-02 | $75.00K derived: sum of 3 quarters · filed 2015-03-02 | $98.00K derived: sum of 4 quarters · filed 2015-03-02 | $48.00K 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $49.00K derived: sum of 2 quarters · filed 2015-03-02 | $72.00K derived: sum of 3 quarters · filed 2015-03-02 | $98.00K 10-K · filed 2015-03-02 | $22.00K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $14.00K 10-Q · filed 2013-11-12 | $14.44K 10-Q · filed 2012-11-14 | $37.00K derived: sum of 2 quarters · filed 2013-11-12 | $63.00K 10-Q · filed 2013-11-12 | $62.60K 10-Q · filed 2012-11-14 | $500.00 derived: sum of 4 quarters · filed 2014-03-03 | -$13.62K 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $23.00K 10-Q · filed 2013-08-06 | $22.52K 10-Q · filed 2012-08-14 | $48.00K 10-Q · filed 2013-08-06 | $48.15K 10-Q · filed 2012-08-14 | -$13.50K derived: sum of 3 quarters · filed 2014-03-03 | -$27.00K derived: sum of 4 quarters · filed 2014-03-03 | -$28.07K 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-03-31 | $26.00K 10-Q · filed 2013-05-09 | $25.64K 10-Q · filed 2012-05-15 | -$36.50K derived: sum of 2 quarters · filed 2014-03-03 | -$50.00K derived: sum of 3 quarters · filed 2014-03-03 | -$50.58K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | -$62.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$76.00K derived: sum of 2 quarters · filed 2014-03-03 | -$76.00K 10-K · filed 2014-03-03 | -$76.22K 10-K · filed 2012-03-29 | -$76.22K 10-K · filed 2012-03-29 | |||||||||||||||
| 2011-09-30 | -$13.50K 10-Q · filed 2012-11-14 | -$13.50K 10-Q · filed 2012-11-14 | -$13.50K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |